Identification of Patients with Low-risk Pulmonary Embolism Suitable for Outpatient Treatment Using the Pulmonary Embolism Severity Index (PESI)

Overview

Journal Ir J Med Sci

Specialty General Medicine

Date 2012 Nov 29

PMID 23188547

Citations 3

Authors

A McCabe

T Hassan

M Doyle

B McCann

Affiliations

Soon will be listed here.

Abstract

Background: There is increasing evidence that outpatient treatment of patients with low-risk stable pulmonary embolism (PE) is safe, effective and potentially reduces costs. It is not clear how many patients presenting to an Irish Emergency Department (ED) are potentially suitable for outpatient management.

Aims: To identify how many patients presenting to our ED over a 1-year period who were diagnosed with acute PE are potentially suitable for outpatient treatment.

Methods: A retrospective observational study was conducted over a 1-year period. Clinical notes for patients who had a positive computed tomographic pulmonary angiogram (CTPA) within 24 h of presentation to the ED were examined to risk stratify the patients according to the pulmonary embolism severity index (PESI).

Results: Forty-seven patients who presented to our ED were diagnosed with a PE. Clinical notes were missing for 3 cases, and 44 cases were analysed further. The mean age was 64.3 (±16.8 SD) years and 24 (54.5 %, 95 % CI 40-68.3 %) were males. Six patients (13.6 %, 95 % CI 6.4-26.7 %) had a background of cancer. Fifteen cases (34.1 %, 95 % CI 21.9-48.7 %) were deemed to be low risk as they were categorised as PESI risk class I or II. Our study found that 61/420 (14.5 %, 95 % CI 11.5-18.2) of CTPAs done were positive for PE.

Conclusion: This study suggests that a significant percentage of patients diagnosed with acute PE are low risk as per PESI and therefore potentially suitable for outpatient management.

Citing Articles

Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis.

Elias A, Mallett S, Daoud-Elias M, Poggi J, Clarke M BMJ Open. 2016; 6(4):e010324.

PMID: 27130162 PMC: 4854007. DOI: 10.1136/bmjopen-2015-010324.

Developments in the management and treatment of pulmonary embolism.

Limbrey R, Howard L Eur Respir Rev. 2015; 24(137):484-97.

PMID: 26324810 PMC: 9487690. DOI: 10.1183/16000617.00006614.

Is the Pulmonary Embolism Severity Index Being Routinely Used in Clinical Practice?.

Shafiq A, Lodhi H, Ahmed Z, Bajwa A Thrombosis. 2015; 2015:175357.

PMID: 26294971 PMC: 4532959. DOI: 10.1155/2015/175357.

References

Aujesky D, Roy P, Verschuren F, Righini M, Osterwalder J, Egloff M . Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011; 378(9785):41-8. DOI: 10.1016/S0140-6736(11)60824-6. View

Mamlouk M, vanSonnenberg E, Gosalia R, Drachman D, Gridley D, Zamora J . Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients. Radiology. 2010; 256(2):625-32. DOI: 10.1148/radiol.10091624. View

Stein P, Goodman L, Hull R, Dalen J, Matta F . Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost. 2011; 18(1):20-6. DOI: 10.1177/1076029611422363. View

Wells P, Kovacs M, Bormanis J, Forgie M, Goudie D, Morrow B . Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Arch Intern Med. 1998; 158(16):1809-12. DOI: 10.1001/archinte.158.16.1809. View

Kovacs M, Anderson D, Morrow B, Gray L, Touchie D, Wells P . Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost. 2000; 83(2):209-11. View

Newcombe R . Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998; 17(8):857-72. DOI: 10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e. View

Donze J, Le Gal G, Fine M, Roy P, Sanchez O, Verschuren F . Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008; 100(5):943-8. DOI: 10.1160/th08-05-0285. View

Erkens P, Gandara E, Wells P, Shen A, Bose G, Le Gal G . Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost. 2010; 8(11):2412-7. DOI: 10.1111/j.1538-7836.2010.04041.x. View

Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P . Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29(18):2276-315. DOI: 10.1093/eurheartj/ehn310. View

10.

Zondag W, Mos I, Creemers-Schild D, Hoogerbrugge A, Dekkers O, Dolsma J . Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011; 9(8):1500-7. DOI: 10.1111/j.1538-7836.2011.04388.x. View

11.

Aujesky D, Obrosky D, Stone R, Auble T, Perrier A, Cornuz J . Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005; 172(8):1041-6. PMC: 2718410. DOI: 10.1164/rccm.200506-862OC. View

12.

Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackle S . Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation. 2002; 106(10):1263-8. DOI: 10.1161/01.cir.0000028422.51668.a2. View

13.

Buller H, Prins M, Lensin A, Decousus H, Jacobson B, Minar E . Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012; 366(14):1287-97. DOI: 10.1056/NEJMoa1113572. View

14.

Kovacs M, Hawel J, Rekman J, Lazo-Langner A . Ambulatory management of pulmonary embolism: a pragmatic evaluation. J Thromb Haemost. 2010; 8(11):2406-11. DOI: 10.1111/j.1538-7836.2010.03981.x. View

15.

Ong B, Karr M, Chan D, Frankel A, Shen Q . Management of pulmonary embolism in the home. Med J Aust. 2005; 183(5):239-42. DOI: 10.5694/j.1326-5377.2005.tb07027.x. View

16.

Nordenholz K, Ryan J, Atwood B, Heard K . Pulmonary embolism risk stratification: pulse oximetry and pulmonary embolism severity index. J Emerg Med. 2009; 40(1):95-102. PMC: 2889188. DOI: 10.1016/j.jemermed.2009.06.004. View

17.

Carrier M, Righini M, Wells P, Perrier A, Anderson D, Rodger M . Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010; 8(8):1716-22. DOI: 10.1111/j.1538-7836.2010.03938.x. View

18.

Kearon C, Kahn S, Agnelli G, Goldhaber S, Raskob G, Comerota A . Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):454S-545S. DOI: 10.1378/chest.08-0658. View

19.

Lui B, Tran A, Montalto M . Treatment of patients with pulmonary embolism entirely in Hospital in the Home. Aust Fam Physician. 2007; 36(5):381-4. View

20.

Nendaz M, Bandelier P, Aujesky D, Cornuz J, Roy P, Bounameaux H . Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost. 2004; 91(6):1232-6. DOI: 10.1160/TH04-01-0034. View